Resubmission includes Chemistry, Manufacturing, and Controls (CMC) data from new drug product (DP) manufacturing vendor Unicycive Therapeutics, Inc.

Salesforce, Inc. (NYSE: CRM) closed at $242.45 on October 19. The stock returned 30.2% over the last 6 months, compared with an 11.6% return for the Insider Monkey Billionaire Index and 8.7% for the ...

J.B. Hunt (NASDAQ:JBHT) reported third-quarter revenue of $3.68 billion last week, up 20% from a year earlier. Diluted earnings came to $1.82 a share, up 3%.

Berkshire Hathaway (NYSE:BRK-B) will soon report its first quarter that includes Taylor Morrison, the homebuilder it agreed to buy for about $6.8 billion in cash.

Procter & Gamble (NYSE:PG) declared its quarterly dividend of $1.0885 per share earlier this month, a payout the company has raised for 70 years in a row.

Eli Lilly (NYSE:LLY) reports third-quarter results in about a week, and the split between volume and price matters more than the headline total.

Johnson & Johnson raised its 2026 forecast earlier this month. It now expects full-year sales of about $101.2 billion at the midpoint, a little higher than its July outlook, and slightly higher ...

HSBC Holdings (NYSE:HSBC) plans to shift senior staff pay from fixed allowances to bonuses starting in 2028, Bloomberg reported this month, citing a memo it had seen.

Amgen (NASDAQ:AMGN) and AstraZeneca reported Phase 3 results this week for Tezspire in eosinophilic esophagitis, a condition that makes swallowing difficult.

Philip Morris International (NYSE:PM) just reported a record quarter that looks like proof its smoke-free bet is working.

KFC plans to start serving Coca-Cola (NYSE:KO) drinks at its U.S. restaurants in January, replacing PepsiCo, The Wall Street Journal reported last week.

C.H. Robinson Worldwide (NASDAQ:CHRW) reports third-quarter results next week, and its last report set a high bar.